Engineering Resistance to Antigen-Specific Immunotherapy in Normal Hematopoietic Stem Cells By Gene Editing to Enable Targeting of Acute Myeloid Leukemia
Author(s) -
Miriam Kim,
Saad S. Kenderian,
Daniel M. Schreeder,
Michael Klichinsky,
Miroslaw Kozlowski,
Olga Shestova,
Marco Ruella,
Saar Gill
Publication year - 2016
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.v128.22.1000.1000
Subject(s) - cd33 , myeloid , myeloid leukemia , haematopoiesis , cd34 , bone marrow , biology , cancer research , immunology , stem cell , antigen , progenitor cell , leukemia , immunotherapy , microbiology and biotechnology , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom